What Impact Does Nice’s Modified Cancer Drugs Fund Process Mean For Patient Access To New Oncology Pharmaceuticals In England?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.369
https://www.valueinhealthjournal.com/article/S1098-3015(17)30703-9/fulltext
Title :
What Impact Does Nice’s Modified Cancer Drugs Fund Process Mean For Patient Access To New Oncology Pharmaceuticals In England?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30703-9&doi=10.1016/j.jval.2017.08.369
First page :
A463
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
342